0 antall prosjekter

H20-HEALTH-Health, demographic change and wellbeing

ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY

ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY

Tildelt: kr 3,5 mill.

Prosjektperiode: 2019-2022

Sted: Oslo

H20-ERC-European Research Council

Oral bacteria as determinants for respiratory health

Oral bacteria as determinants for respiratory health

Tildelt: kr 14,4 mill.

Prosjektperiode: 2019-2023

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Advanced Secure Cloud Encrypted Platform for Internationally Orchestrated Solutions in Healthcare

Advanced Secure Cloud Encrypted Platform for Internationally Orchestrated Solutions in Healthcare

Tildelt: kr 6,3 mill.

Prosjektperiode: 2018-2022

Sted: Troms - Romsa - Tromssa

H20-CROSST-Cross-theme

System for AcceleroMeter-Based Assessment of cardiac FUNction

In patients undergoing open-heart surgeries, perioperative cardiac monitoring is used to track the functioning of the heart and identify complications. However, myocardial failure and other severe complications can escape detection using current monitoring technologies, given the trade-offs betwe...

Tildelt: kr 15,0 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-ERC-European Research Council

Set to change: early life factors restricting and promoting neurocognitive plasticity through life

Cognitive function in old age can be predicted from how you functioned when you were young. This is remarkable, as there are substantial cognitive age changes. Are we neurodevelopmentally set to change through life in certain ways? The objective of Set-to-change is to test whether and how early l...

Tildelt: kr 18,7 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

MAnufacturing of TUmour-REactive Natural Killer cells

This project will provide future-oriented translational research training designed to bridge the gap between basic research and applied development of new cell-based therapeutic products by the biotech industry and their clinical use for incurable diseases. This will be done on the example of act...

Tildelt: kr 2,7 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Tildelt: kr 6,5 mill.

Prosjektperiode: 2018-2024

Sted: Vestland

H20-INFRA-Research infrastructures

EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts

EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts

Tildelt: kr 0,90 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

A European Training Network for Functional Hybrid Coatings by Molecular Layer Deposition

HYCOAT is the first ETN at the intersection of chemistry, physics, materials science and engineering dealing with the synthesis and applications of hybrid coatings grown by molecular layer deposition (MLD). With self-limiting binary reactions, MLD is the ideal ultra-thin film deposition technique...

Tildelt: kr 5,3 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory and there are many un...

Tildelt: kr 1,2 mill.

Prosjektperiode: 2018-2022

Sted: Innlandet

H20-HEALTH-Health, demographic change and wellbeing

Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial

TENSION (efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window: a randomized, controlled trial) strives at providing innovative treatment to patients with severe stroke to reduce the individual and societal burden of death and dependency from stroke. To this ...

Tildelt: kr 2,4 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative

Bipolar disorder (BD) is a prevalent mental disorder and a leading cause of suicide. Lithium (Li) is the key mood stabilizer for prevention of BD relapse and suicide. Whilst many cases become asymptomatic with Li treatment, the majority show sub-optimal response. Identifying biomarkers for predic...

Tildelt: kr 1,7 mill.

Prosjektperiode: 2018-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock

Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock

Tildelt: kr 2,8 mill.

Prosjektperiode: 2018-2022

Sted: Troms - Romsa - Tromssa

H20-ERC-European Research Council

Imaging Perfusion Restrictions from Extracellular Solid Stress

Imaging Perfusion Restrictions from Extracellular Solid Stress

Tildelt: kr 14,0 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Personalised maxillofacial bone regeneration

Tildelt: kr 9,1 mill.

Prosjektperiode: 2018-2021

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Empathic, Expressive, Advanced Virtual Coach to Improve Independent Healthy-Life-Years of the Elderly

Empathic, Expressive, Advanced Virtual Coach to Improve Independent Healthy-Life-Years of the Elderly

Tildelt: kr 4,1 mill.

Prosjektperiode: 2017-2021

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Personalised In-Silico Cardiology

Improving healthcare systems mandates a shift towards personalised and preventive management of disease. Specifically, the management of cardiovascular diseases has a huge impact on European society in terms of mortality, morbidity and healthcare costs, being responsible for 1.9 million deaths in...

Tildelt: kr 8,0 mill.

Prosjektperiode: 2017-2022

Sted: Oslo og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

International impact of TALK©: a simple and practical approach to multi-professional structured feedback and debriefing, to be used after unplanned learning events in clinical environments.

International impact of TALK©: a simple and practical approach to multi-professional structured feedback and debriefing, to be used after unplanned learning events in clinical environments.

Tildelt: kr 0,50 mill.

Prosjektperiode: 2017-2022

Sted: Rogaland

H20-MSCA-Marie Sklodowska-Curie actions

Supporting Pioneer doctoral Researchers through 3i Knowledge partnerships

Supporting Pioneer doctoral Researchers through 3i Knowledge partnerships

Tildelt: Skjult

Prosjektperiode: 2017-2022

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

FrontierResearchCompentences@CNAP

Chronic pain is a key societal challenge affecting one out of five adults and is in general poorly treated. This programme, FrontierResearchCompentences@CNAP (FRESCO@CNAP), aims to install 8 early stage researchers (ESRs) in a Centre-of-Excellence (CNAP) conducting frontline research on novel too...

Tildelt: Skjult

Prosjektperiode: 2017-2022

Sted: Oslo

H20-INFRA-Research infrastructures

Paediatric Clinical Research Infrastructure Network

Paediatric Clinical Research Infrastructure Network

Tildelt: kr 0,45 mill.

Prosjektperiode: 2017-2021

Sted: Trøndelag - Trööndelage og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

Tildelt: kr 5,1 mill.

Prosjektperiode: 2017-2021

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

Tildelt: kr 2,7 mill.

Prosjektperiode: 2016-2021

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

High Performance Soft-tissue Navigation

Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue ...

Tildelt: kr 15,0 mill.

Prosjektperiode: 2016-2021

Sted: Trøndelag - Trööndelage og 2 andre

H20-FET-Future and Emerging Technologies

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours

Tildelt: kr 14,5 mill.

Prosjektperiode: 2016-2022

Sted: Oslo

H20-SECURITY-Secure societies - Protecting freedom and security of Europe and its citizens

EnhANcing emergencY management and response to extreme WeatHER and climate Events

EnhANcing emergencY management and response to extreme WeatHER and climate Events

Tildelt: kr 5,6 mill.

Prosjektperiode: 2016-2019

Sted: Trøndelag - Trööndelage og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

Tildelt: kr 5,1 mill.

Prosjektperiode: 2016-2019

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome

Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of death or long-term disability in infants born at term in the western world, affecting about 1-4 per 1.000 life births and consequently about 5-20.000 infants per year in Europe. Hypothermic treatment became the only established th...

Tildelt: kr 1,9 mill.

Prosjektperiode: 2016-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Tildelt: kr 2,4 mill.

Prosjektperiode: 2016-2020

Sted: Vestland

H20-TWINING-Twinning of research institutions

Strategies towards Excellence in Immuno-Oncology

Strategies towards Excellence in Immuno-Oncology

Tildelt: kr 1,5 mill.

Prosjektperiode: 2016-2018

Sted: Oslo